Revenue: The sum of all revenue fields included for a company's operating activities.
Amicus Therapeutics, Inc. (FOLD) had Revenue of $399.36M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
Revenue |
$399.36M |
$-151.58M |
|
$37.33M |
|
$362.03M |
|
$476.57M |
|
$-77.21M |
|
$-72.89M |
|
$-150.10M |
|
$-150.10M |
|
$-151.58M |
|
$-151.58M |
|
$-151.58M |
|
$-151.58M |
|
$-77.21M |
|
$-66.72M |
|
295.16M |
|
295.16M |
|
$-0.51 |
|
$-0.51 |
|
Balance Sheet Financials | |
$483.06M |
|
$31.67M |
|
$294.82M |
|
$777.88M |
|
$167.69M |
|
$387.86M |
|
$450.02M |
|
$617.71M |
|
$160.17M |
|
$-58.11M |
|
$160.17M |
|
293.59M |
|
Cash Flow Statement Financials | |
$-69.09M |
|
$98.06M |
|
$61.68M |
|
$153.12M |
|
$250.08M |
|
$96.96M |
|
$86.08M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
0.71 |
|
2.42 |
|
90.65% |
|
-19.33% |
|
-19.33% |
|
-16.71% |
|
-37.59% |
|
-37.96% |
|
$-76.53M |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
0.63 |
|
4.56 |
|
80.09 |
|
-94.64% |
|
260.84% |
|
-19.49% |
|
-27.66% |
|
$0.55 |
|
$-0.26 |
|
$-0.23 |